The Global Fund signed 157 grants for a total of US$8.54 billion for lifesaving HIV, TB and malaria programs and to strengthen systems for health, according to a press statement.
“This is an exceptional achievement that will help more than 100 countries continue the critical fight against HIV, TB and malaria – epidemics that kill more than 2.3 million people every year”
“As the COVID-19 pandemic overwhelms health systems around the world, it is now more important than ever that we ensure countries have the resources they need to fight HIV, TB and malaria and to strengthen the systems for health needed to respond to all four diseases,” Peter Sands, Executive Director of the Global Fund said.
The grants due to begin this month are the highest amount of grants ever signed in a single year by the Global Fund.
The Global Fund has a total of US$12.71 billion available in funding allocations for the three-year funding cycle that runs from 2020-2022. Of these funds, the Global Fund had planned for US$8.9 billion in grants to be approved in 2020, with the remaining funds scheduled for later start dates.
“Even in the midst of a new global pandemic, during an extraordinarily challenging year, the Global Fund partnership has supported countries to develop grants more quickly and effectively than ever before”
“A record-breaking 67% of grants for the 2020-2022 funding cycle have now been signed, compared to 50% of grants signed at the same time in the last funding cycle, representing a remarkable increase in performance,” said Donald Kaberuka, Global Fund Board Chair.
On top of the new grants awarded to fight HIV, TB and malaria, the Global Fund has approved US$980 million in additional funding to 106 low- and middle-income countries and 14 multicountry programs to respond to COVID-19 in 2020.